🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial has two parts. The purpose of the first part of the trial is to ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-12
Trial ID
NCT00267748
Treatments Being Tested
The purpose of this study is to find out what effects, good and/or bad, sun...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2007-10
Trial ID
NCT00589784
Treatments Being Tested
The purpose of this research study is to determine the safety and tolerabil...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2014-07
Trial ID
NCT02164240
Treatments Being Tested
This is a study using sunitinib for patients ending treatment on a previous...
Status
Completed
Location
Emory University, Winship Cancer Institute
Start Date
2007-07
Trial ID
NCT00428220
Treatments Being Tested
To evaluate the antitumor activity of SU011248 in advanced, imatinib mesyla...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-09
Trial ID
NCT00137449
Treatments Being Tested
This study is to evaluate the safety of SU011248 in combination with paclit...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-09
Trial ID
NCT00174434
Treatments Being Tested
Primary Objectives To determine maxi tolerated dose \& dose limiting toxici...
Status
Completed
Location
Duke University Health System
Start Date
2008-03
Trial ID
NCT00611728
Treatments Being Tested
The purpose of the study is to evaluate the effect of Sunitinib on the clin...
Status
Completed
Location
Aichi Cancer Center Central Hospital
Start Date
2010-07
Trial ID
NCT01121562
Treatments Being Tested
The purpose of this study is to determine whether sutent (sunitinib)is effe...
Status
Terminated
Location
University of Michigan
Start Date
2009-09
Trial ID
NCT01042795
Treatments Being Tested
To evaluate the anti-tumor activity of SU011248 (sunitinib) in cytokine-ref...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-05
Trial ID
NCT00137423
Treatments Being Tested